임상시험 용품 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 임상 단계별, 제품 및 서비스별, 치료 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Clinical Trial Supplies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Clinical Phase, By Product & Services, By Therapeutic Use, By End User, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,444,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,877,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,457,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

임상시험 용품 세계 시장 규모는 2024년 28억 1,000만 달러로 2030년까지 7.43%의 CAGR로 2030년에는 43억 3,000만 달러에 달할 것으로 예상됩니다.

전 세계적으로 임상시험의 양과 복잡성이 증가함에 따라 임상시험 시장은 지속적으로 성장하고 있습니다. 제약 및 바이오 제약 기업들이 새로운 치료법 개발을 가속화함에 따라 합리적이고 신뢰할 수 있으며 컴플라이언스를 준수하는 공급망에 대한 수요가 증가하고 있습니다. 임상시험은 지리적으로 분산되어 있고, 기간이 길어지고 있으며, 규제 요건이 더욱 엄격해지고 있습니다. 이에 따라 효율적인 물류, 온도 관리 보관, 실시간 추적 시스템에 대한 필요성이 증가하고 있습니다. 적응성 높은 임상시험 설계와 맞춤형 의료의 채택은 공급 프로세스를 더욱 복잡하게 만들고 있으며, 스폰서들은 유연하고 확장 가능한 공급 파트너를 찾고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	28억 1,000만 달러
시장 규모 : 2030년	43억 3,000만 달러
CAGR : 2025-2030년	7.43%
급성장 부문	심혈관질환
최대 시장	북미

임상시험 물류 시장의 핵심 트렌드는 임상시험 물류에 디지털 기술이 통합되고 있다는 점입니다. 분산형 및 하이브리드 임상시험 모델의 부상으로 임상시험 의뢰자와 임상시험수탁기관(CRO)은 DTP(Direct to Patient) 공급 전략을 채택하고 모니터링, 예측, 재고 관리를 위해 디지털 도구를 채택하고 있습니다. 수요 계획 및 데이터 분석을 위한 첨단 소프트웨어 플랫폼의 도입은 낭비를 줄이고, 정확성을 높이며, 실시간 의사결정을 내리는 데 도움이 되고 있습니다. 스마트 포장, 데이터 보안을 위한 블록체인, AI 기반 예측과 같은 혁신은 업무 효율성 향상과 규제 준수를 보장하기 위해 활용되고 있습니다.

주요 시장 촉진요인

치료 영역 전반에 걸친 임상시험 수 증가

주요 시장 과제

세계 공급망 관리의 복잡성

주요 시장 동향

공급망 디지털화 및 실시간 모니터링 채택 증가

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 임상시험 용품 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 임상 단계별(단계 I, 단계 II, 단계 III, 기타)
  • 제품 및 서비스별(제조, 보관·배송, 공급망 관리)
  • 치료 용도별(종양학, 중추신경계 질환, 심혈관질환, 감염증, 대사질환, 기타)
  • 최종사용자별(의약품, 생물학적 제제, 의료기기, 기타)
  • 기업별(2024년)
  • 지역별
• 시장 맵

제6장 북미의 임상시험 용품 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 임상시험 용품 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 임상시험 용품 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 임상시험 용품 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 임상시험 용품 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제14장 경쟁 구도

• Thermo Fisher Scientific Inc.
• Almac Group
• Novo Holdings A/S
• Marken(UPS)
• PCI Pharma Services
• Sharp Services LLC
• Cencora, Inc.
• Myonex
• Parexel International Corporation
• ICON Plc

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

ksm

영문 목차

영문목차

The Global Clinical Trial Supplies Market was valued at USD 2.81 billion in 2024 and is expected to reach USD 4.33 billion by 2030, growing at a CAGR of 7.43% through 2030. The market is experiencing sustained growth due to the increasing volume and complexity of clinical trials globally. As pharmaceutical and biopharmaceutical companies aim to accelerate the development of new therapies, the demand for streamlined, reliable, and compliant supply chains has intensified. Clinical trials are becoming more geographically dispersed, longer in duration, and subject to stricter regulatory requirements. This increases the need for efficient logistics, temperature-controlled storage, and real-time tracking systems. The adoption of adaptive trial designs and personalized medicine is further complicating the supply process, prompting sponsors to seek supply partners with flexible and scalable capabilities.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.81 Billion
Market Size 2030	USD 4.33 Billion
CAGR 2025-2030	7.43%
Fastest Growing Segment	Cardiovascular Diseases
Largest Market	North America

A significant trend shaping the market is the integration of digital technologies in clinical trial logistics. The rise of decentralized and hybrid trial models is pushing sponsors and contract research organizations (CROs) to adopt direct-to-patient (DTP) supply strategies and employ digital tools for monitoring, forecasting, and inventory control. The implementation of advanced software platforms for demand planning and data analytics is helping reduce waste, improve accuracy, and support real-time decision-making. Innovations like smart packaging, blockchain for data security, and AI-driven forecasting are being leveraged to enhance operational efficiency and ensure regulatory compliance.

Key Market Drivers

Rising Number of Clinical Trials Across Therapeutic Areas

The increasing number of clinical trials across various therapeutic areas is a key driver for the Global Clinical Trial Supplies Market. Pharmaceutical, biotechnology, and medical device companies are expanding their research and development pipelines, leading to a surge in clinical research activities. This growth is fueled by increased investments in drug discovery and innovation, along with the growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and autoimmune conditions. As new molecules and biologics enter the clinical stage, the demand for efficient and reliable supply chains becomes critical. Sponsors require specialized logistics and packaging services to support complex trial protocols, manage temperature-sensitive products, and ensure the timely delivery of investigational medicinal products (IMPs) to global trial sites.

According to the World Health Organization's International Clinical Trials Registry Platform (ICTRP), the number of newly recruiting trials has steadily increased, with significant growth in regions such as South-East Asia, especially in India. This upward trend in clinical trial activity necessitates robust clinical trial supply chains to handle the increasing complexity and volume of trials. The rise of decentralized trials and direct-to-patient models has further emphasized the need for innovative supply strategies and cold chain infrastructure.

Key Market Challenges

Complexity in Managing Global Supply Chains

Managing global supply chains in the clinical trial supplies market presents significant logistical challenges. Clinical trials are increasingly conducted across multiple countries, complicating supply chain coordination due to varying timelines, different customs regulations, local language requirements, and multiple vendor engagements. Fluctuations in demand forecasts, unpredictable patient enrollment, and protocol amendments further strain supply planning and inventory management. Maintaining drug stability, ensuring timely delivery of investigational products, and preventing stockouts or wastage require highly responsive and adaptive systems. Specialized cold chain logistics and real-time monitoring become even more critical for temperature-sensitive drugs and biologics. As trials move toward decentralized models with direct-to-patient delivery and remote participation, the supply chain must evolve to remain flexible while maintaining quality and compliance. These challenges often add significant costs to trial budgets.

Key Market Trends

Increased Adoption of Supply Chain Digitalization and Real-Time Monitoring

The adoption of supply chain digitalization and real-time monitoring is transforming the operational landscape of the global clinical trial supplies market. Pharmaceutical sponsors and contract research organizations are prioritizing end-to-end visibility to manage the growing complexities of clinical trials. Digital platforms such as Interactive Response Technology (IRT), cloud-based inventory systems, and IoT-enabled tracking tools are becoming essential in enhancing supply chain responsiveness and transparency. These platforms provide real-time insights into drug availability, temperature control, and shipment progress, enabling supply managers to proactively address issues such as stockouts, wastage, and delays.

Real-time monitoring tools ensure compliance with stringent regulatory requirements by capturing data on temperature excursions, delivery confirmations, and chain-of-custody records. This is especially important for sensitive investigational products like biologics and personalized therapies. Predictive analytics integrated with these digital systems can forecast demand fluctuations and help optimize resupply strategies, improving trial continuity. Sponsors gain greater control, reducing risks and enhancing the patient experience by ensuring timely and reliable delivery of trial materials.

Key Market Players

• Thermo Fisher Scientific Inc.
• Almac Group
• Novo Holdings A/S
• Marken (UPS)
• PCI Pharma Services
• Sharp Services LLC
• Cencora, Inc.
• Myonex
• Parexel International Corporation
• ICON Plc

Report Scope:

In this report, the Global Clinical Trial Supplies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trial Supplies Market, By Clinical Phase:

• Phase I
• Phase II
• Phase III
• Others

Clinical Trial Supplies Market, By Product & Services:

• Manufacturing
• Storage & Distribution
• Supply Chain Management

Clinical Trial Supplies Market, By Therapeutic Use:

• Oncology
• CNS Diseases
• Cardiovascular Diseases
• Infectious Disease
• Metabolic Disorders
• Others

Clinical Trial Supplies Market, By End User:

• Pharmaceutical
• Biologics
• Medical Device
• Others

Clinical Trial Supplies Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Trial Supplies Market.

Available Customizations:

Global Clinical Trial Supplies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Clinical Trial Supplies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Clinical Phase (Phase I, Phase II, Phase III, Others)
  • 5.2.2. By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management)
  • 5.2.3. By Therapeutic Use (Oncology, CNS Diseases, Cardiovascular Diseases, Infectious Disease, Metabolic Disorders, Others)
  • 5.2.4. By End User (Pharmaceutical, Biologics, Medical device, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Clinical Trial Supplies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Clinical Phase
  • 6.2.2. By Product & Services
  • 6.2.3. By Therapeutic Use
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Clinical Trial Supplies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Clinical Phase
      • 6.3.1.2.2. By Product & Services
      • 6.3.1.2.3. By Therapeutic Use
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Clinical Trial Supplies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Clinical Phase
      • 6.3.2.2.2. By Product & Services
      • 6.3.2.2.3. By Therapeutic Use
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Clinical Trial Supplies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Clinical Phase
      • 6.3.3.2.2. By Product & Services
      • 6.3.3.2.3. By Therapeutic Use
      • 6.3.3.2.4. By End User

7. Europe Clinical Trial Supplies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Clinical Phase
  • 7.2.2. By Product & Services
  • 7.2.3. By Therapeutic Use
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Clinical Trial Supplies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Clinical Phase
      • 7.3.1.2.2. By Product & Services
      • 7.3.1.2.3. By Therapeutic Use
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Clinical Trial Supplies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Clinical Phase
      • 7.3.2.2.2. By Product & Services
      • 7.3.2.2.3. By Therapeutic Use
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Clinical Trial Supplies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Clinical Phase
      • 7.3.3.2.2. By Product & Services
      • 7.3.3.2.3. By Therapeutic Use
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Clinical Trial Supplies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Clinical Phase
      • 7.3.4.2.2. By Product & Services
      • 7.3.4.2.3. By Therapeutic Use
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Clinical Trial Supplies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Clinical Phase
      • 7.3.5.2.2. By Product & Services
      • 7.3.5.2.3. By Therapeutic Use
      • 7.3.5.2.4. By End User

8. Asia-Pacific Clinical Trial Supplies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Clinical Phase
  • 8.2.2. By Product & Services
  • 8.2.3. By Therapeutic Use
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Clinical Trial Supplies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Clinical Phase
      • 8.3.1.2.2. By Product & Services
      • 8.3.1.2.3. By Therapeutic Use
      • 8.3.1.2.4. By End User
  • 8.3.2. India Clinical Trial Supplies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Clinical Phase
      • 8.3.2.2.2. By Product & Services
      • 8.3.2.2.3. By Therapeutic Use
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Clinical Trial Supplies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Clinical Phase
      • 8.3.3.2.2. By Product & Services
      • 8.3.3.2.3. By Therapeutic Use
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Clinical Trial Supplies Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Clinical Phase
      • 8.3.4.2.2. By Product & Services
      • 8.3.4.2.3. By Therapeutic Use
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Clinical Trial Supplies Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Clinical Phase
      • 8.3.5.2.2. By Product & Services
      • 8.3.5.2.3. By Therapeutic Use
      • 8.3.5.2.4. By End User

9. South America Clinical Trial Supplies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Clinical Phase
  • 9.2.2. By Product & Services
  • 9.2.3. By Therapeutic Use
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Clinical Trial Supplies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Clinical Phase
      • 9.3.1.2.2. By Product & Services
      • 9.3.1.2.3. By Therapeutic Use
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Clinical Trial Supplies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Clinical Phase
      • 9.3.2.2.2. By Product & Services
      • 9.3.2.2.3. By Therapeutic Use
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Clinical Trial Supplies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Clinical Phase
      • 9.3.3.2.2. By Product & Services
      • 9.3.3.2.3. By Therapeutic Use
      • 9.3.3.2.4. By End User

10. Middle East and Africa Clinical Trial Supplies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Clinical Phase
  • 10.2.2. By Product & Services
  • 10.2.3. By Therapeutic Use
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Clinical Trial Supplies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Clinical Phase
      • 10.3.1.2.2. By Product & Services
      • 10.3.1.2.3. By Therapeutic Use
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Clinical Trial Supplies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Clinical Phase
      • 10.3.2.2.2. By Product & Services
      • 10.3.2.2.3. By Therapeutic Use
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Clinical Trial Supplies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Clinical Phase
      • 10.3.3.2.2. By Product & Services
      • 10.3.3.2.3. By Therapeutic Use
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Almac Group
• 14.3. Novo Holdings A/S
• 14.4. Marken (UPS)
• 14.5. PCI Pharma Services
• 14.6. Sharp Services LLC
• 14.7. Cencora, Inc.
• 14.8. Myonex
• 14.9. Parexel International Corporation
• 14.10. ICON Plc

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료